IN THIS ARTICLE

Citations

1. Nathan DM, et al. (2007). Impaired fasting glucose and impaired glucose tolerance. Diabetes Care, 30(3): 753–759.

2. Diabetes Prevention Program Research Group (2009). 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet, 374: 1677–1686.

3. American Diabetes Association (2012). Standards of medical care in diabetes—2012. Diabetes Care, 35(Suppl 1): S11–S63.

4. American Diabetes Association (2004). Smoking and diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S74–S75.

5. Diabetes Prevention Program Research Group (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6): 393–403.

6. American Diabetes Association (2004). Prevention or delay of type 2 diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S47–S50.

Other Works Consulted

• Buse JB, et al. (2008). Type 2 diabetes mellitus. In PR Larsen et al., eds., Williams Textbook of Endocrinology, 11th ed., pp. 1329–1381. Philadelphia: Saunders Elsevier.

• McCall AL, Saunders JT (2009). Metabolic disorders. In RE Rakel, ET Bope, eds., Conn's Current Therapy, pp. 575–583. Philadelphia: Saunders Elsevier.

• National Diabetes Education Program (2006). Small steps, big rewards: Your game plan for preventing type 2 diabetes. Available online: http://ndep.nih.gov.

• Norris SL, et al. (2005). Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database of Systematic Reviews. Oxford: Update Software.

• Rao SS, et al. (2004). Impaired glucose tolerance and impaired fasting glucose. American Family Physician, 69(8): 1961–1968.

• Riddle MC, Genuth S (2010). Type 2 diabetes mellitus. In EG Nabel, ed., ACP Medicine, section 9, chap. 2. Hamilton, ON: BC Decker.